Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Merith Basey (Patients for AffordableDrugs, Washington, DC,USA) told The Lancet Oncology that she was particularly concerned about what she called a “poison pill” part of Trump’s executive order that orders a potential change in how some drugs are costed. Under a law brought in under the Biden administration, Medicare can negotiate the price of some […]
News and Reports
Patients for Affordable Drugs, a patient advocacy organization, called the provision on the negotiation program “deeply harmful.” “Delaying Medicare negotiation for small-molecule drugs – the most commonly used medications – is a clear giveaway to Big Pharma. It would hand drug companies four additional years to price-gouge patients, one in three of whom can’t afford […]
News and Reports
Fierce Healthcare: Trump order seeks changes to Medicare drug price negotiation program, PBM reform
The provision’s inclusion was not supported by Patients for Affordable Drugs, calling it a “deeply harmful” item that caves to pharmaceutical lobbyists. “It would hand drug companies four additional years to price-gouge patients, one in three of whom can’t afford their prescription drugs today,” said Executive Director Merith Basey. “This change isn’t about supporting innovation […]
News and Reports
Healthcare Finance: Trump's executive order on drugs seeks to end pharma 'pill penalty'
Merith Basey, executive director of Patients For Affordable Drugs, said the small molecule provision in the EO caves to pharmaceutical lobbyists’ demands. “Delaying Medicare negotiation for small-molecule drugs – the most commonly used medications – is a clear giveaway to Big Pharma,” Basey said. “It would hand drug companies four additional years to price-gouge patients, […]
News and Reports
“Make no mistake,” Patients for Affordable Drugs executive director Merith Basey said of the legislation, “this is yet another attempt by Big Pharma to rig the system in its favor—at the expense of patients.”
News and Reports
“Make no mistake,” said Merith Basey, executive director of Patients for Affordable Drugs, “this is yet another attempt by Big Pharma to rig the system in its favor—at the expense of patients.”
News and Reports
Fierce Pharma: Trump throws pharma 'bread crumb' concession with call to end IRA pill penalty
In her own statement, Merith Basey, executive director of Patients for Affordable Drugs, agreed that the proposed elimination of the pill penalty is “a clear giveaway to Big Pharma.”
News and Reports
NBC 5: President Trump says tariffs on pharmaceuticals are coming soon
“One in three people cannot afford to fill their prescription drugs today,” said Patients for Affordable Drugs Executive Director Merith Basey. “There is real concern, understandably, that these tariffs would increase costs for patients and make their lives much harder.”